{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:21:25Z","timestamp":1783444885734,"version":"3.54.6"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajo.2026.04.004","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:15:53Z","timestamp":1776107753000},"page":"92-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinicopathological and Imaging Distinction Between Ocular Adnexal MALT Lymphoma and IgG4-Related Ophthalmic Disease"],"prefix":"10.1016","volume":"288","author":[{"given":"Hao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2026.04.004_bib0001","first-page":"140","article-title":"Extranodal marginal zone B-cell lymphoma of the ocular adnexa","volume":"23","author":"Guffey Johnson","year":"2016","journal-title":"Cancer Cntrl"},{"issue":"2","key":"10.1016\/j.ajo.2026.04.004_bib0002","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/apm.13017","article-title":"The role of infectious agents in cancer of the ocular region","volume":"128","author":"Henriksen","year":"2020","journal-title":"Apmis"},{"key":"10.1016\/j.ajo.2026.04.004_bib0003","first-page":"92","article-title":"IgG4-releated disease. Onemocn\u011bn\u00ed asociovan\u00e9 s IgG4","volume":"34","author":"Adam","year":"2021","journal-title":"Klin Onkol"},{"key":"10.1016\/j.ajo.2026.04.004_bib0004","doi-asserted-by":"crossref","unstructured":"Maehara T, Pillai S, Stone JH, et al. Clinical features and mechanistic insights regarding IgG4-related dacryoadenitis and sialoadenitis: a review. Int J Oral Maxillofac Surg. 48(7):908\u2013916. doi:10.1016\/j.ijom.2019.01.006.","DOI":"10.1016\/j.ijom.2019.01.006"},{"issue":"1","key":"10.1016\/j.ajo.2026.04.004_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/tjo.tjo_12_17","article-title":"Immunoglobulin G4-related ophthalmic disease","volume":"8","author":"Yu","year":"2018","journal-title":"Taiwan J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2026.04.004_bib0006","first-page":"716","article-title":"Diagnosis and treatment of MALT lymphoma in ocular adnexa","volume":"56","author":"Guiqiu","year":"2020","journal-title":"Chin J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2026.04.004_bib0007","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ajo.2026.04.004_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10384-014-0352-2","article-title":"Japanese Study Group for IgG4-Related Ophthalmic Disease. Diagnostic criteria for IgG4-related ophthalmic disease","volume":"59","author":"Goto","year":"2015","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.04.004_bib0009","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League against rheumatism classification criteria for IgG4-related disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ajo.2026.04.004_bib0010","doi-asserted-by":"crossref","first-page":"259408","DOI":"10.1155\/2012\/259408","article-title":"Development of an IgG4-RD responder index","volume":"2012","author":"Carruthers","year":"2012","journal-title":"Int J Rheumatol"},{"issue":"8","key":"10.1016\/j.ajo.2026.04.004_bib0011","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/modpathol.2012.68","article-title":"Distinct histopathological features of Hashimoto\u2019s thyroiditis with respect to IgG4-related disease","volume":"25","author":"Li","year":"2012","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.ajo.2026.04.004_bib0012","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/rheumatology\/key397","article-title":"Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients","volume":"58","author":"Wang","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.ajo.2026.04.004_bib0013","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1755-3768.2012.02526.x","article-title":"IgG4-related orbital disease: a meta-analysis and review","volume":"91","author":"Andrew","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.04.004_bib0014","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13075-021-02489-9","article-title":"Clinical features and relapse risks of IgG4-related ophthalmic disease: a single-center experience in China","volume":"23","author":"Zhao","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.ajo.2026.04.004_bib0015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/1744666X.2019.1560268","article-title":"New insights into the pathophysiology of IgG4-related disease and markers of disease activity","volume":"15","author":"Yamada","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"10.1016\/j.ajo.2026.04.004_bib0016","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00417-013-2548-4","article-title":"Location and frequency of lesions in patients with IgG4-related ophthalmic diseases","volume":"252","author":"Sogabe","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2026.04.004_bib0017","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","article-title":"Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients","volume":"54","author":"Lin","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajo.2026.04.004_bib0018","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajoc.2018.01.017","article-title":"Immunoglobulin G4-related dacyroadenitis presenting as bilateral chorioretinal folds from severely enlarged lacrimal glands","volume":"9","author":"Kurokawa","year":"2018","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"1","key":"10.1016\/j.ajo.2026.04.004_bib0019","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.survophthal.2018.08.002","article-title":"Orbital lymphoma","volume":"64","author":"Olsen","year":"2019","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2026.04.004_bib0020","first-page":"832","article-title":"The imaging signs and significances of the enlargement of the infraorbital nerve and the frontal nerve in orbital lymphoproliferative diseases","volume":"56","author":"Wang","year":"2020","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"1","key":"10.1016\/j.ajo.2026.04.004_bib0021","first-page":"53","article-title":"Value of the apparent diffusion coefficient in diffusion weighted imaging at 3.0T MR for differentiating lacrimal gland tumors","volume":"99","author":"Wang","year":"2019","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.ajo.2026.04.004_bib0022","first-page":"91","article-title":"Quantitative analysis of dynamic contrast-enhanced MRI in conjunction with diffusion weighted imaging for differentiating benign and malignant orbital lymphoproliferative disorder","volume":"52","author":"Qian","year":"2018","journal-title":"Chin J Radiol"},{"issue":"9","key":"10.1016\/j.ajo.2026.04.004_bib0023","first-page":"716","article-title":"Diagnosis and treatment of ocular adnexal MALT lymphoma","volume":"56","author":"Zhao","year":"2020","journal-title":"Chin J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.04.004_bib0024","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","article-title":"4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ajo.2026.04.004_bib0025","first-page":"688","article-title":"Clinical types and individualized treatments of primary ocular adnexal MALT lymphoma","volume":"36","author":"Yu","year":"2021","journal-title":"Eye Sci"},{"issue":"7","key":"10.1016\/j.ajo.2026.04.004_bib0026","first-page":"481","article-title":"Clinical analysis of ocular adnexa mucosa-associated lymphoid tissue lymphomas","volume":"41","author":"Lijuan","year":"2019","journal-title":"Chin J Ocular Trauma Occupational Eye Dis"},{"issue":"5","key":"10.1016\/j.ajo.2026.04.004_bib0027","first-page":"257","article-title":"Pay attention to the application of radiotherapy in the treatment of ocular tumors and orbital diseases","volume":"11","author":"Jianmin","year":"2021","journal-title":"Chin J Ophthalmol Med (Electronic Edition)"},{"issue":"1","key":"10.1016\/j.ajo.2026.04.004_bib0028","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajo.2026.04.004_bib0029","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/apm.12845","article-title":"IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach","volume":"126","author":"Bledsoe","year":"2018","journal-title":"APMIS"},{"issue":"6","key":"10.1016\/j.ajo.2026.04.004_bib0030","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00405-021-07083-y","article-title":"Serum immunoglobulin G4 has limited diagnostic value in immunoglobulin G4-related chronic rhinosinusitis","volume":"279","author":"Wan","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"10.1016\/j.ajo.2026.04.004_bib0031","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ajg.2016.40","article-title":"Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK Cohort","volume":"111","author":"Culver","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.ajo.2026.04.004_bib0032","first-page":"1323","article-title":"Serum IgG4 concentration in IgG4-related disease","volume":"63","author":"Kawa","year":"2017","journal-title":"Clin Lab"},{"issue":"12","key":"10.1016\/j.ajo.2026.04.004_bib0033","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s10067-017-3685-7","article-title":"Diagnostic performances of serum IgG4 concentration and IgG4\/IgG ratio in IgG4-related disease","volume":"36","author":"Xia","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.ajo.2026.04.004_bib0034","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/bjophthalmol-2017-311519","article-title":"Clinicoserological factors associated with response to steroid treatment and recurrence in patients with IgG4-related ophthalmic disease","volume":"102","author":"Hong","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.04.004_bib0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13000-021-01139-7","article-title":"T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis","volume":"16","author":"Zhu","year":"2021","journal-title":"Diagn Pathol"},{"issue":"4","key":"10.1016\/j.ajo.2026.04.004_bib0036","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s10384-017-0513-1","article-title":"Immunophenotypic profiles for distinguishing orbital mucosa-associated lymphoid tissue lymphoma from benign lymphoproliferative tumors","volume":"61","author":"Ueda","year":"2017","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.04.004_bib0037","doi-asserted-by":"crossref","first-page":"100101","DOI":"10.1016\/j.apjo.2024.100101","article-title":"Advances in understanding and management of IgG4-related ophthalmic disease","volume":"13","author":"Lai","year":"2024","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"3","key":"10.1016\/j.ajo.2026.04.004_bib0038","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4103\/1319-4534.343368","article-title":"Ocular adnexal lymphoma: a single-institution retrospective study","volume":"35","author":"Fern\u00e1ndez","year":"2022","journal-title":"Saudi J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.04.004_bib0039","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/cancers14051264","article-title":"The biology of ocular adnexal marginal zone lymphomas","volume":"14","author":"Johansson","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ajo.2026.04.004_bib0040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12886-021-02115-x","article-title":"IgG4-related disease in patients with idiopathic orbital inflammation","volume":"21","author":"Aryasit","year":"2021","journal-title":"BMC Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2026.04.004_bib0041","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.3390\/biomedicines13092311","article-title":"IgG4-related orbital disease vs. idiopathic orbital inflammation: clinical features, therapy and outcomes in a Central-European retrospective single-center cohort","volume":"13","author":"Rattunde","year":"2025","journal-title":"Biomedicines"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426001790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426001790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:28:14Z","timestamp":1783441694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426001790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"alternative-id":["S0002939426001790"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.04.004","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological and Imaging Distinction Between Ocular Adnexal MALT Lymphoma and IgG4-Related Ophthalmic Disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}